PRO/EDR> Leishmaniasis – India: miltefosine resistance

Leishmaniasis — India
Cutaneous leishmaniasis [CL] is an ulcerous skin disease caused by a tropical parasite [_Leishmania_ spp.], all forms of which can be treated with the drug miltefosine.
Researchers from the National Institute of Pathology, Indian Council of Medical Research and Safdarjung Hospital in Delhi studied the responses of 86 patients treated with miltefosine over 18 months, which indicated a developing parasitic resistance to the drug, supporting a growing evidence base showing the rise of